nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—ALB—melanoma	0.364	1	CbGaD
Sulfamethoxazole—ALB—Vemurafenib—melanoma	0.16	0.502	CbGbCtD
Sulfamethoxazole—CYP3A4—Temozolomide—melanoma	0.0918	0.287	CbGbCtD
Sulfamethoxazole—CYP3A4—Vemurafenib—melanoma	0.0503	0.157	CbGbCtD
Sulfamethoxazole—CYP3A4—Docetaxel—melanoma	0.0173	0.054	CbGbCtD
Sulfamethoxazole—Photosensitivity—Vemurafenib—melanoma	0.00248	0.0118	CcSEcCtD
Sulfamethoxazole—Digestion impaired—Temozolomide—melanoma	0.0023	0.0109	CcSEcCtD
Sulfamethoxazole—Apathy—Temozolomide—melanoma	0.00215	0.0102	CcSEcCtD
Sulfamethoxazole—Flat affect—Temozolomide—melanoma	0.00213	0.0101	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00196	0.00934	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Vemurafenib—melanoma	0.00186	0.00888	CcSEcCtD
Sulfamethoxazole—Systemic lupus erythematosus—Docetaxel—melanoma	0.00184	0.00877	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Vemurafenib—melanoma	0.00172	0.00818	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Vemurafenib—melanoma	0.00168	0.00799	CcSEcCtD
Sulfamethoxazole—Infestation—Vemurafenib—melanoma	0.00168	0.00799	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00166	0.00792	CcSEcCtD
Sulfamethoxazole—Eruption—Docetaxel—melanoma	0.00166	0.00789	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Vemurafenib—melanoma	0.00165	0.00783	CcSEcCtD
Sulfamethoxazole—Hepatic enzyme increased—Temozolomide—melanoma	0.00162	0.00772	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Dactinomycin—melanoma	0.00159	0.00758	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Vemurafenib—melanoma	0.00148	0.00705	CcSEcCtD
Sulfamethoxazole—Aplastic anaemia—Temozolomide—melanoma	0.00144	0.00686	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Vemurafenib—melanoma	0.00143	0.00678	CcSEcCtD
Sulfamethoxazole—Eye disorder—Vemurafenib—melanoma	0.00141	0.00671	CcSEcCtD
Sulfamethoxazole—Neuritis—Docetaxel—melanoma	0.00137	0.0065	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Vemurafenib—melanoma	0.00136	0.00647	CcSEcCtD
Sulfamethoxazole—Chills—Vemurafenib—melanoma	0.00135	0.00644	CcSEcCtD
Sulfamethoxazole—Malnutrition—Vemurafenib—melanoma	0.00131	0.00625	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Temozolomide—melanoma	0.00124	0.00593	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Temozolomide—melanoma	0.00118	0.00562	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Carmustine—melanoma	0.00116	0.00551	CcSEcCtD
Sulfamethoxazole—Purpura—Temozolomide—melanoma	0.00116	0.0055	CcSEcCtD
Sulfamethoxazole—Cough—Vemurafenib—melanoma	0.00115	0.00545	CcSEcCtD
Sulfamethoxazole—Myalgia—Vemurafenib—melanoma	0.00112	0.00532	CcSEcCtD
Sulfamethoxazole—Arthralgia—Vemurafenib—melanoma	0.00112	0.00532	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00111	0.00528	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00111	0.00528	CcSEcCtD
Sulfamethoxazole—Oliguria—Docetaxel—melanoma	0.00111	0.00527	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Bleomycin—melanoma	0.00108	0.00516	CcSEcCtD
Sulfamethoxazole—Ataxia—Carmustine—melanoma	0.00108	0.00516	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Vemurafenib—melanoma	0.00107	0.0051	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Vemurafenib—melanoma	0.00105	0.005	CcSEcCtD
Sulfamethoxazole—Ataxia—Temozolomide—melanoma	0.00105	0.00498	CcSEcCtD
Sulfamethoxazole—Skin disorder—Vemurafenib—melanoma	0.00104	0.00495	CcSEcCtD
Sulfamethoxazole—Pneumonia—Bleomycin—melanoma	0.00102	0.00487	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Dactinomycin—melanoma	0.00101	0.00481	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Temozolomide—melanoma	0.001	0.00477	CcSEcCtD
Sulfamethoxazole—Neutropenia—Dactinomycin—melanoma	0.000995	0.00474	CcSEcCtD
Sulfamethoxazole—Stomatitis—Bleomycin—melanoma	0.000992	0.00472	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000976	0.00464	CcSEcCtD
Sulfamethoxazole—Pneumonia—Dactinomycin—melanoma	0.000954	0.00454	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Carmustine—melanoma	0.000946	0.0045	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000941	0.00448	CcSEcCtD
Sulfamethoxazole—Neutropenia—Carmustine—melanoma	0.000931	0.00443	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Vemurafenib—melanoma	0.000931	0.00443	CcSEcCtD
Sulfamethoxazole—Stomatitis—Dactinomycin—melanoma	0.000925	0.0044	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Vemurafenib—melanoma	0.000925	0.0044	CcSEcCtD
Sulfamethoxazole—Fatigue—Vemurafenib—melanoma	0.000923	0.00439	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Temozolomide—melanoma	0.000914	0.00435	CcSEcCtD
Sulfamethoxazole—Neutropenia—Temozolomide—melanoma	0.0009	0.00428	CcSEcCtD
Sulfamethoxazole—Pneumonia—Carmustine—melanoma	0.000893	0.00425	CcSEcCtD
Sulfamethoxazole—Depression—Carmustine—melanoma	0.000886	0.00421	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Dactinomycin—melanoma	0.000886	0.00421	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Temozolomide—melanoma	0.000879	0.00418	CcSEcCtD
Sulfamethoxazole—Renal failure—Carmustine—melanoma	0.000873	0.00415	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Carmustine—melanoma	0.000871	0.00414	CcSEcCtD
Sulfamethoxazole—Stomatitis—Carmustine—melanoma	0.000866	0.00412	CcSEcCtD
Sulfamethoxazole—Pneumonia—Temozolomide—melanoma	0.000863	0.00411	CcSEcCtD
Sulfamethoxazole—Infestation—Temozolomide—melanoma	0.000858	0.00408	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Temozolomide—melanoma	0.000858	0.00408	CcSEcCtD
Sulfamethoxazole—Depression—Temozolomide—melanoma	0.000856	0.00407	CcSEcCtD
Sulfamethoxazole—Hepatitis—Dactinomycin—melanoma	0.000852	0.00405	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000851	0.00405	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vemurafenib—melanoma	0.000847	0.00403	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Temozolomide—melanoma	0.000841	0.004	CcSEcCtD
Sulfamethoxazole—Stomatitis—Temozolomide—melanoma	0.000837	0.00398	CcSEcCtD
Sulfamethoxazole—Chills—Bleomycin—melanoma	0.00082	0.0039	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Temozolomide—melanoma	0.000812	0.00386	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Dactinomycin—melanoma	0.000805	0.00383	CcSEcCtD
Sulfamethoxazole—Hallucination—Carmustine—melanoma	0.000793	0.00378	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vemurafenib—melanoma	0.000789	0.00376	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Carmustine—melanoma	0.000783	0.00373	CcSEcCtD
Sulfamethoxazole—Renal impairment—Docetaxel—melanoma	0.000778	0.0037	CcSEcCtD
Sulfamethoxazole—Hepatitis—Temozolomide—melanoma	0.00077	0.00367	CcSEcCtD
Sulfamethoxazole—Asthenia—Vemurafenib—melanoma	0.000768	0.00366	CcSEcCtD
Sulfamethoxazole—Hallucination—Temozolomide—melanoma	0.000767	0.00365	CcSEcCtD
Sulfamethoxazole—Chills—Dactinomycin—melanoma	0.000764	0.00364	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Temozolomide—melanoma	0.000761	0.00362	CcSEcCtD
Sulfamethoxazole—Pruritus—Vemurafenib—melanoma	0.000758	0.00361	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Temozolomide—melanoma	0.000757	0.0036	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Temozolomide—melanoma	0.000755	0.00359	CcSEcCtD
Sulfamethoxazole—Eye disorder—Carmustine—melanoma	0.000745	0.00355	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Docetaxel—melanoma	0.000744	0.00354	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vemurafenib—melanoma	0.000733	0.00349	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Temozolomide—melanoma	0.000728	0.00347	CcSEcCtD
Sulfamethoxazole—Eye disorder—Temozolomide—melanoma	0.00072	0.00343	CcSEcCtD
Sulfamethoxazole—Tinnitus—Temozolomide—melanoma	0.000718	0.00342	CcSEcCtD
Sulfamethoxazole—Leukopenia—Bleomycin—melanoma	0.000712	0.00339	CcSEcCtD
Sulfamethoxazole—Dizziness—Vemurafenib—melanoma	0.000708	0.00337	CcSEcCtD
Sulfamethoxazole—Mental disorder—Carmustine—melanoma	0.000698	0.00332	CcSEcCtD
Sulfamethoxazole—Ataxia—Docetaxel—melanoma	0.000696	0.00331	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Temozolomide—melanoma	0.000696	0.00331	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Temozolomide—melanoma	0.000694	0.0033	CcSEcCtD
Sulfamethoxazole—Malnutrition—Carmustine—melanoma	0.000694	0.0033	CcSEcCtD
Sulfamethoxazole—Cough—Bleomycin—melanoma	0.000694	0.0033	CcSEcCtD
Sulfamethoxazole—Chills—Temozolomide—melanoma	0.000691	0.00329	CcSEcCtD
Sulfamethoxazole—Vomiting—Vemurafenib—melanoma	0.000681	0.00324	CcSEcCtD
Sulfamethoxazole—Myalgia—Bleomycin—melanoma	0.000677	0.00322	CcSEcCtD
Sulfamethoxazole—Rash—Vemurafenib—melanoma	0.000675	0.00321	CcSEcCtD
Sulfamethoxazole—Mental disorder—Temozolomide—melanoma	0.000675	0.00321	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vemurafenib—melanoma	0.000675	0.00321	CcSEcCtD
Sulfamethoxazole—Headache—Vemurafenib—melanoma	0.000671	0.00319	CcSEcCtD
Sulfamethoxazole—Malnutrition—Temozolomide—melanoma	0.000671	0.00319	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000667	0.00317	CcSEcCtD
Sulfamethoxazole—Leukopenia—Dactinomycin—melanoma	0.000664	0.00316	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Bleomycin—melanoma	0.000649	0.00309	CcSEcCtD
Sulfamethoxazole—Nausea—Vemurafenib—melanoma	0.000636	0.00303	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Bleomycin—melanoma	0.000635	0.00302	CcSEcCtD
Sulfamethoxazole—Myalgia—Dactinomycin—melanoma	0.000631	0.003	CcSEcCtD
Sulfamethoxazole—Leukopenia—Carmustine—melanoma	0.000621	0.00296	CcSEcCtD
Sulfamethoxazole—Anorexia—Bleomycin—melanoma	0.000619	0.00294	CcSEcCtD
Sulfamethoxazole—Angioedema—Temozolomide—melanoma	0.000613	0.00292	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Docetaxel—melanoma	0.000608	0.00289	CcSEcCtD
Sulfamethoxazole—Vertigo—Temozolomide—melanoma	0.000603	0.00287	CcSEcCtD
Sulfamethoxazole—Convulsion—Carmustine—melanoma	0.000601	0.00286	CcSEcCtD
Sulfamethoxazole—Leukopenia—Temozolomide—melanoma	0.0006	0.00286	CcSEcCtD
Sulfamethoxazole—Neutropenia—Docetaxel—melanoma	0.000599	0.00285	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Dactinomycin—melanoma	0.000593	0.00282	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Bleomycin—melanoma	0.000591	0.00281	CcSEcCtD
Sulfamethoxazole—Myalgia—Carmustine—melanoma	0.000591	0.00281	CcSEcCtD
Sulfamethoxazole—Cough—Temozolomide—melanoma	0.000585	0.00279	CcSEcCtD
Sulfamethoxazole—Convulsion—Temozolomide—melanoma	0.000581	0.00277	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Bleomycin—melanoma	0.000579	0.00275	CcSEcCtD
Sulfamethoxazole—Anorexia—Dactinomycin—melanoma	0.000577	0.00275	CcSEcCtD
Sulfamethoxazole—Pneumonia—Docetaxel—melanoma	0.000574	0.00273	CcSEcCtD
Sulfamethoxazole—Myalgia—Temozolomide—melanoma	0.000571	0.00272	CcSEcCtD
Sulfamethoxazole—Arthralgia—Temozolomide—melanoma	0.000571	0.00272	CcSEcCtD
Sulfamethoxazole—Infestation—Docetaxel—melanoma	0.000571	0.00272	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Docetaxel—melanoma	0.000571	0.00272	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000567	0.0027	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000566	0.00269	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Bleomycin—melanoma	0.000564	0.00268	CcSEcCtD
Sulfamethoxazole—Renal failure—Docetaxel—melanoma	0.000561	0.00267	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Docetaxel—melanoma	0.000559	0.00266	CcSEcCtD
Sulfamethoxazole—Stomatitis—Docetaxel—melanoma	0.000556	0.00265	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Carmustine—melanoma	0.000555	0.00264	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000551	0.00262	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Temozolomide—melanoma	0.000547	0.00261	CcSEcCtD
Sulfamethoxazole—Anorexia—Carmustine—melanoma	0.00054	0.00257	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Docetaxel—melanoma	0.00054	0.00257	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Temozolomide—melanoma	0.000537	0.00255	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Temozolomide—melanoma	0.000536	0.00255	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Docetaxel—melanoma	0.000533	0.00253	CcSEcCtD
Sulfamethoxazole—Skin disorder—Temozolomide—melanoma	0.000532	0.00253	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Dactinomycin—melanoma	0.000526	0.0025	CcSEcCtD
Sulfamethoxazole—Fatigue—Dactinomycin—melanoma	0.000522	0.00248	CcSEcCtD
Sulfamethoxazole—Anorexia—Temozolomide—melanoma	0.000522	0.00248	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Carmustine—melanoma	0.000516	0.00246	CcSEcCtD
Sulfamethoxazole—Urticaria—Bleomycin—melanoma	0.000516	0.00245	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Bleomycin—melanoma	0.000513	0.00244	CcSEcCtD
Sulfamethoxazole—Hepatitis—Docetaxel—melanoma	0.000512	0.00244	CcSEcCtD
Sulfamethoxazole—Insomnia—Carmustine—melanoma	0.000512	0.00244	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Docetaxel—melanoma	0.000506	0.00241	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Carmustine—melanoma	0.000505	0.0024	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Docetaxel—melanoma	0.000503	0.0024	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Docetaxel—melanoma	0.000502	0.00239	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Temozolomide—melanoma	0.000499	0.00237	CcSEcCtD
Sulfamethoxazole—Insomnia—Temozolomide—melanoma	0.000495	0.00236	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Dactinomycin—melanoma	0.000495	0.00236	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Carmustine—melanoma	0.000492	0.00234	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Carmustine—melanoma	0.000489	0.00233	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Temozolomide—melanoma	0.000488	0.00232	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Docetaxel—melanoma	0.000484	0.00231	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Temozolomide—melanoma	0.000482	0.00229	CcSEcCtD
Sulfamethoxazole—Eye disorder—Docetaxel—melanoma	0.000479	0.00228	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Dactinomycin—melanoma	0.000478	0.00228	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Dactinomycin—melanoma	0.000478	0.00228	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Bleomycin—melanoma	0.000478	0.00228	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Temozolomide—melanoma	0.000476	0.00226	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Temozolomide—melanoma	0.000473	0.00225	CcSEcCtD
Sulfamethoxazole—Fatigue—Temozolomide—melanoma	0.000472	0.00225	CcSEcCtD
Sulfamethoxazole—Asthenia—Bleomycin—melanoma	0.000466	0.00222	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Carmustine—melanoma	0.000463	0.0022	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Docetaxel—melanoma	0.000463	0.0022	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Docetaxel—melanoma	0.000462	0.0022	CcSEcCtD
Sulfamethoxazole—Chills—Docetaxel—melanoma	0.00046	0.00219	CcSEcCtD
Sulfamethoxazole—Pruritus—Bleomycin—melanoma	0.000459	0.00219	CcSEcCtD
Sulfamethoxazole—Mental disorder—Docetaxel—melanoma	0.000449	0.00214	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Carmustine—melanoma	0.000448	0.00213	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Carmustine—melanoma	0.000448	0.00213	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Temozolomide—melanoma	0.000448	0.00213	CcSEcCtD
Sulfamethoxazole—Malnutrition—Docetaxel—melanoma	0.000446	0.00212	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Dactinomycin—melanoma	0.000446	0.00212	CcSEcCtD
Sulfamethoxazole—Urticaria—Temozolomide—melanoma	0.000435	0.00207	CcSEcCtD
Sulfamethoxazole—Asthenia—Dactinomycin—melanoma	0.000434	0.00207	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Temozolomide—melanoma	0.000433	0.00206	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Temozolomide—melanoma	0.000433	0.00206	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Carmustine—melanoma	0.000417	0.00199	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Dactinomycin—melanoma	0.000414	0.00197	CcSEcCtD
Sulfamethoxazole—Vomiting—Bleomycin—melanoma	0.000413	0.00196	CcSEcCtD
Sulfamethoxazole—Rash—Bleomycin—melanoma	0.000409	0.00195	CcSEcCtD
Sulfamethoxazole—Dermatitis—Bleomycin—melanoma	0.000409	0.00195	CcSEcCtD
Sulfamethoxazole—Asthenia—Carmustine—melanoma	0.000406	0.00193	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Temozolomide—melanoma	0.000403	0.00192	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—melanoma	0.000399	0.0019	CcSEcCtD
Sulfamethoxazole—Asthenia—Temozolomide—melanoma	0.000393	0.00187	CcSEcCtD
Sulfamethoxazole—Cough—Docetaxel—melanoma	0.000389	0.00185	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Carmustine—melanoma	0.000388	0.00184	CcSEcCtD
Sulfamethoxazole—Pruritus—Temozolomide—melanoma	0.000387	0.00184	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—melanoma	0.000386	0.00184	CcSEcCtD
Sulfamethoxazole—Nausea—Bleomycin—melanoma	0.000385	0.00183	CcSEcCtD
Sulfamethoxazole—Vomiting—Dactinomycin—melanoma	0.000385	0.00183	CcSEcCtD
Sulfamethoxazole—Rash—Dactinomycin—melanoma	0.000382	0.00182	CcSEcCtD
Sulfamethoxazole—Arthralgia—Docetaxel—melanoma	0.00038	0.00181	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—melanoma	0.00038	0.00181	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000377	0.00179	CcSEcCtD
Sulfamethoxazole—Dizziness—Carmustine—melanoma	0.000375	0.00178	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Temozolomide—melanoma	0.000375	0.00178	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—melanoma	0.000364	0.00173	CcSEcCtD
Sulfamethoxazole—Dizziness—Temozolomide—melanoma	0.000362	0.00172	CcSEcCtD
Sulfamethoxazole—Vomiting—Carmustine—melanoma	0.00036	0.00171	CcSEcCtD
Sulfamethoxazole—Nausea—Dactinomycin—melanoma	0.000359	0.00171	CcSEcCtD
Sulfamethoxazole—Rash—Carmustine—melanoma	0.000357	0.0017	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—melanoma	0.000357	0.0017	CcSEcCtD
Sulfamethoxazole—Dermatitis—Carmustine—melanoma	0.000357	0.0017	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—melanoma	0.000356	0.0017	CcSEcCtD
Sulfamethoxazole—Headache—Carmustine—melanoma	0.000355	0.00169	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—melanoma	0.000354	0.00168	CcSEcCtD
Sulfamethoxazole—Sulfamethazine—ALB—melanoma	0.000352	0.322	CrCbGaD
Sulfamethoxazole—Vomiting—Temozolomide—melanoma	0.000348	0.00166	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—melanoma	0.000347	0.00165	CcSEcCtD
Sulfamethoxazole—Rash—Temozolomide—melanoma	0.000345	0.00164	CcSEcCtD
Sulfamethoxazole—Dermatitis—Temozolomide—melanoma	0.000345	0.00164	CcSEcCtD
Sulfamethoxazole—Sulfamerazine—ALB—melanoma	0.000344	0.314	CrCbGaD
Sulfamethoxazole—Headache—Temozolomide—melanoma	0.000343	0.00163	CcSEcCtD
Sulfamethoxazole—Nausea—Carmustine—melanoma	0.000336	0.0016	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—melanoma	0.000332	0.00158	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—melanoma	0.000329	0.00157	CcSEcCtD
Sulfamethoxazole—Nausea—Temozolomide—melanoma	0.000325	0.00155	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—melanoma	0.000325	0.00154	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—melanoma	0.00032	0.00153	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—melanoma	0.000316	0.00151	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—melanoma	0.000314	0.0015	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—melanoma	0.000314	0.00149	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—melanoma	0.000298	0.00142	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—melanoma	0.000288	0.00137	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—melanoma	0.000288	0.00137	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—melanoma	0.000268	0.00128	CcSEcCtD
Sulfamethoxazole—Sulfamethizole—ALB—melanoma	0.000267	0.244	CrCbGaD
Sulfamethoxazole—Asthenia—Docetaxel—melanoma	0.000261	0.00124	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—melanoma	0.000258	0.00123	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—melanoma	0.000249	0.00119	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—melanoma	0.000241	0.00115	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—melanoma	0.000231	0.0011	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—melanoma	0.00023	0.00109	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—melanoma	0.000229	0.00109	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—melanoma	0.000228	0.00109	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—melanoma	0.000216	0.00103	CcSEcCtD
Sulfamethoxazole—Dapsone—PTGS2—melanoma	0.000132	0.12	CrCbGaD
Sulfamethoxazole—ALB—Hemostasis—AKT3—melanoma	3.65e-05	0.000349	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC6A11—melanoma	3.63e-05	0.000347	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIP4K2A—melanoma	3.63e-05	0.000347	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IFNA2—melanoma	3.57e-05	0.000341	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—MTAP—melanoma	3.55e-05	0.000339	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	3.55e-05	0.000339	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—MTAP—melanoma	3.53e-05	0.000338	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP17A1—melanoma	3.49e-05	0.000333	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.47e-05	0.000332	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	3.45e-05	0.00033	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.44e-05	0.000329	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—ALB—melanoma	3.4e-05	0.000325	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—VCAN—melanoma	3.37e-05	0.000322	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	3.36e-05	0.000321	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	3.35e-05	0.00032	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—melanoma	3.32e-05	0.000317	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—ITGB1—melanoma	3.32e-05	0.000317	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GNA11—melanoma	3.3e-05	0.000315	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ACER3—melanoma	3.24e-05	0.000309	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—FASN—melanoma	3.23e-05	0.000308	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.19e-05	0.000305	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC5A5—melanoma	3.17e-05	0.000303	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PHGDH—melanoma	3.17e-05	0.000303	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—LUM—melanoma	3.17e-05	0.000303	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLCB4—melanoma	3.16e-05	0.000302	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—LUM—melanoma	3.15e-05	0.000301	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PHGDH—melanoma	3.15e-05	0.000301	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—HPSE—melanoma	3.11e-05	0.000297	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—melanoma	3.1e-05	0.000296	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—HPSE—melanoma	3.09e-05	0.000295	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PPARG—melanoma	3.08e-05	0.000294	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	3.08e-05	0.000294	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CD44—melanoma	3.07e-05	0.000293	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—GNAQ—melanoma	3.07e-05	0.000293	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CUBN—melanoma	3.05e-05	0.000291	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HGF—melanoma	3.03e-05	0.00029	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CUBN—melanoma	3.03e-05	0.00029	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3e-05	0.000287	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CSF2—melanoma	3e-05	0.000286	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIP4K2A—melanoma	2.97e-05	0.000284	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC6A11—melanoma	2.97e-05	0.000284	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.97e-05	0.000284	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—UGT2B10—melanoma	2.96e-05	0.000283	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BSG—melanoma	2.95e-05	0.000281	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SDHD—melanoma	2.95e-05	0.000281	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CSPG4—melanoma	2.95e-05	0.000281	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1B1—melanoma	2.94e-05	0.000281	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SDHD—melanoma	2.93e-05	0.00028	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BSG—melanoma	2.93e-05	0.00028	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CSPG4—melanoma	2.93e-05	0.00028	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—MTAP—melanoma	2.89e-05	0.000276	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—ITGB3—melanoma	2.88e-05	0.000275	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PRKCA—melanoma	2.88e-05	0.000275	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GPAM—melanoma	2.85e-05	0.000272	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP17A1—melanoma	2.85e-05	0.000272	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GPAM—melanoma	2.84e-05	0.000271	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	2.83e-05	0.00027	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.81e-05	0.000268	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—ALB—melanoma	2.77e-05	0.000265	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HS3ST5—melanoma	2.75e-05	0.000263	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	2.71e-05	0.000258	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GNA11—melanoma	2.69e-05	0.000257	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAC1—melanoma	2.67e-05	0.000255	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—FASN—melanoma	2.63e-05	0.000251	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	2.61e-05	0.00025	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.59e-05	0.000248	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC5A5—melanoma	2.59e-05	0.000247	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MMP1—melanoma	2.58e-05	0.000246	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—LUM—melanoma	2.58e-05	0.000246	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PHGDH—melanoma	2.58e-05	0.000246	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CDK2—melanoma	2.53e-05	0.000242	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—HPSE—melanoma	2.53e-05	0.000241	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CD44—melanoma	2.5e-05	0.000239	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—GNAQ—melanoma	2.5e-05	0.000239	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CUBN—melanoma	2.48e-05	0.000237	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	2.47e-05	0.000236	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.45e-05	0.000234	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PLA2G6—melanoma	2.43e-05	0.000232	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.42e-05	0.000231	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ABCB1—melanoma	2.42e-05	0.000231	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PLA2G6—melanoma	2.41e-05	0.00023	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CSPG4—melanoma	2.4e-05	0.000229	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BSG—melanoma	2.4e-05	0.000229	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SDHD—melanoma	2.4e-05	0.000229	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1B1—melanoma	2.4e-05	0.000229	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—FN1—melanoma	2.35e-05	0.000225	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	2.35e-05	0.000225	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—melanoma	2.34e-05	0.000224	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NOS2—melanoma	2.33e-05	0.000222	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GPAM—melanoma	2.32e-05	0.000222	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CG—melanoma	2.25e-05	0.000215	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PRKCA—melanoma	2.23e-05	0.000213	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—EGF—melanoma	2.23e-05	0.000213	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ERCC2—melanoma	2.21e-05	0.000211	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—VCAN—melanoma	2.18e-05	0.000208	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—VCAN—melanoma	2.17e-05	0.000207	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.11e-05	0.000202	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLCB4—melanoma	2.09e-05	0.000199	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.06e-05	0.000197	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IGF1—melanoma	2.06e-05	0.000197	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.05e-05	0.000196	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	2.04e-05	0.000195	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.99e-05	0.00019	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CD—melanoma	1.98e-05	0.000189	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.98e-05	0.000189	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PLA2G6—melanoma	1.97e-05	0.000189	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCB1—melanoma	1.97e-05	0.000188	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC6A11—melanoma	1.96e-05	0.000187	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIP4K2A—melanoma	1.96e-05	0.000187	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—melanoma	1.91e-05	0.000183	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—MTAP—melanoma	1.91e-05	0.000182	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP17A1—melanoma	1.84e-05	0.000176	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.83e-05	0.000175	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP17A1—melanoma	1.83e-05	0.000175	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PRKCA—melanoma	1.82e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.81e-05	0.000173	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.8e-05	0.000172	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ERCC2—melanoma	1.8e-05	0.000172	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.79e-05	0.000171	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—VCAN—melanoma	1.77e-05	0.000169	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—melanoma	1.74e-05	0.000167	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GNA11—melanoma	1.74e-05	0.000166	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GNA11—melanoma	1.73e-05	0.000165	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CB—melanoma	1.73e-05	0.000165	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—LUM—melanoma	1.7e-05	0.000162	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PHGDH—melanoma	1.7e-05	0.000162	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—FASN—melanoma	1.7e-05	0.000162	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—FASN—melanoma	1.69e-05	0.000161	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPARG—melanoma	1.68e-05	0.000161	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.68e-05	0.00016	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A5—melanoma	1.67e-05	0.00016	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—HPSE—melanoma	1.67e-05	0.000159	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	1.67e-05	0.000159	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A5—melanoma	1.66e-05	0.000159	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CUBN—melanoma	1.64e-05	0.000156	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.62e-05	0.000155	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—GNAQ—melanoma	1.61e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CD44—melanoma	1.61e-05	0.000154	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—GNAQ—melanoma	1.6e-05	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CD44—melanoma	1.6e-05	0.000153	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—melanoma	1.59e-05	0.000151	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SDHD—melanoma	1.58e-05	0.000151	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CSPG4—melanoma	1.58e-05	0.000151	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BSG—melanoma	1.58e-05	0.000151	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.58e-05	0.000151	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.57e-05	0.00015	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.57e-05	0.00015	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.56e-05	0.000149	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1B1—melanoma	1.55e-05	0.000148	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1B1—melanoma	1.54e-05	0.000147	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CD—melanoma	1.53e-05	0.000146	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GPAM—melanoma	1.53e-05	0.000146	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ALB—melanoma	1.51e-05	0.000145	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP17A1—melanoma	1.5e-05	0.000143	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.49e-05	0.000142	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.48e-05	0.000141	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.46e-05	0.000139	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—melanoma	1.42e-05	0.000136	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GNA11—melanoma	1.41e-05	0.000135	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FASN—melanoma	1.38e-05	0.000132	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPARG—melanoma	1.37e-05	0.000131	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.37e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A5—melanoma	1.36e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.36e-05	0.00013	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—melanoma	1.35e-05	0.000129	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CB—melanoma	1.34e-05	0.000128	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NRAS—melanoma	1.33e-05	0.000127	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTGS2—melanoma	1.32e-05	0.000126	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—GNAQ—melanoma	1.31e-05	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CD44—melanoma	1.31e-05	0.000125	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PLA2G6—melanoma	1.3e-05	0.000124	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.29e-05	0.000123	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.27e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—melanoma	1.27e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—melanoma	1.27e-05	0.000122	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—melanoma	1.27e-05	0.000121	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1B1—melanoma	1.26e-05	0.00012	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CD—melanoma	1.25e-05	0.000119	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ALB—melanoma	1.23e-05	0.000118	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK1—melanoma	1.21e-05	0.000116	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PRKCA—melanoma	1.17e-05	0.000112	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—VCAN—melanoma	1.17e-05	0.000112	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PRKCA—melanoma	1.17e-05	0.000111	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ERCC2—melanoma	1.16e-05	0.000111	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ERCC2—melanoma	1.16e-05	0.00011	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—melanoma	1.16e-05	0.00011	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—melanoma	1.15e-05	0.000109	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.11e-05	0.000106	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CB—melanoma	1.09e-05	0.000104	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTGS2—melanoma	1.08e-05	0.000103	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—melanoma	1.05e-05	0.0001	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—melanoma	1.04e-05	9.9e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—melanoma	1.02e-05	9.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP17A1—melanoma	9.87e-06	9.42e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—melanoma	9.74e-06	9.3e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.63e-06	9.2e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.58e-06	9.15e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PRKCA—melanoma	9.54e-06	9.11e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ERCC2—melanoma	9.47e-06	9.04e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—melanoma	9.42e-06	8.99e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GNA11—melanoma	9.32e-06	8.9e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—melanoma	9.19e-06	8.77e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—melanoma	9.13e-06	8.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FASN—melanoma	9.12e-06	8.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A5—melanoma	8.97e-06	8.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPARG—melanoma	8.87e-06	8.47e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPARG—melanoma	8.81e-06	8.42e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—GNAQ—melanoma	8.66e-06	8.27e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CD44—melanoma	8.66e-06	8.27e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—melanoma	8.6e-06	8.21e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1B1—melanoma	8.31e-06	7.93e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—melanoma	8.15e-06	7.78e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CD—melanoma	8.08e-06	7.71e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CD—melanoma	8.03e-06	7.67e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ALB—melanoma	7.97e-06	7.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.84e-06	7.49e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—melanoma	7.48e-06	7.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPARG—melanoma	7.22e-06	6.89e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CB—melanoma	7.04e-06	6.72e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CB—melanoma	7e-06	6.68e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTGS2—melanoma	6.97e-06	6.66e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTGS2—melanoma	6.93e-06	6.62e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—melanoma	6.84e-06	6.53e-05	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—melanoma	6.66e-06	6.36e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—melanoma	6.64e-06	6.34e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CD—melanoma	6.57e-06	6.28e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ALB—melanoma	6.49e-06	6.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PRKCA—melanoma	6.29e-06	6.01e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ERCC2—melanoma	6.24e-06	5.96e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—melanoma	6.08e-06	5.81e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—melanoma	6.05e-06	5.77e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CB—melanoma	5.73e-06	5.47e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTGS2—melanoma	5.68e-06	5.42e-05	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—melanoma	5.43e-06	5.18e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—melanoma	4.95e-06	4.73e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—melanoma	4.93e-06	4.71e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPARG—melanoma	4.76e-06	4.54e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CD—melanoma	4.33e-06	4.14e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—melanoma	4.29e-06	4.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ALB—melanoma	4.28e-06	4.09e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—melanoma	4.27e-06	4.07e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CB—melanoma	3.78e-06	3.61e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTGS2—melanoma	3.74e-06	3.57e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—melanoma	3.51e-06	3.35e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—melanoma	3.49e-06	3.33e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—melanoma	3.49e-06	3.33e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—melanoma	3.26e-06	3.12e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—melanoma	2.85e-06	2.72e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—melanoma	2.3e-06	2.2e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—melanoma	1.88e-06	1.8e-05	CbGpPWpGaD
